Post by Replasia BV

🍾 𝗕𝗶𝗴 𝗡𝗲𝘄𝘀: 𝗥𝗲𝗽𝗹𝗮𝘀𝗶𝗮 𝘄𝗲𝗹𝗰𝗼𝗺𝗲𝘀 𝗻𝗲𝘄 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀! 🍾 We are thrilled to announce that we received a minority investment from Materialise and medtech entrepreneur Andy Christensen.   This investment is a strong validation of our technology and our vision to optimize existing joint preservation treatments, like we do with our 𝗛𝗶𝗽𝗦𝘁𝘂𝗱𝗶𝗼 anatomical analysis service and to develop bold innovative solutions like our 𝟯𝗗 𝗦𝗵𝗲𝗹𝗳 personalized hip implant for the treatment of hip dysplasia in young adults, which is currently tested in a 𝗳𝗶𝗿𝘀𝘁-𝗶𝗻-𝗵𝘂𝗺𝗮𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 in the Netherlands.   With Materialise's deep expertise in medical 3D technology and Andy's outstanding track record and experience in development and commercialization of personalized medical devices, we gain two exceptional partners who will support us in accelerating our product development and market introductions, both in 𝗘𝘂𝗿𝗼𝗽𝗲 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗨𝗦𝗔.   Replasia remains fully independent and we continue to welcome collaboration with like minded innovative surgeons and companies that share our commitment to improving patient outcomes. We believe that great innovation often arises at the crossroads of technologies and thrives through openness and multi-disciplinary collaboration and for that our doors will always be wide open. 🤝 Thank you to our new investors for their trust and confidence in what we are building. Exciting times ahead of us! 🚀 #Replasia #Investment #3DPrinting #Orthopedics #HipPreservation #MedTech #Innovation #Materialise